A critical appraisal of the quality of 18F-FDG PET/CT guidelines in oncology using the AGREE II tool: A EuroAIM initiative
European Journal of Radiology Mar 13, 2020
Romeo V, Stanzione A, Gaudieri V, et al. - This study was carried out to evaluate the quality of guidelines on clinical indications for the use of 18F-FDG PET/CT in oncology using the AGREE II tool. The current literature was searched to identify guidelines focused on clinical indications for the use of 18F-FDG PET/CT in oncology between March and May 2019. Four independent appraisers assessed the quality of the selected guidelines using the AGREE II tool, which is organized in six quality domains accounting for a total of 23 items. It is demonstrated that a heterogeneous quality of guidelines dealing with clinical indications for the use of 18F-FDG PET/CT in oncology emerged from this analysis. Further study is needed to enhance the reporting of the applied methodology as well as to promote the applicability of guidelines into clinical practice.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries